NCT02918357 · OUTCOME

Safety Assessment - Heart Rate

Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence · Source last updated 2019-12-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

What was measured

Patient vital signs were measured before and after 68Ga-PSMA-11 injections and absolute mean change was calculated.

All patients were assessed for safety measures that included Heart Rate before infusion

All patients were assessed for safety measures that included Heart Rate after infusion

All subjects had the absolute mean in heart rate calculated to assess for safety

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Pre-Infusion Heart Rate	385
Post-Infusion Heart Rate	385
Absolute Change in Heart Rate	385

Source class 1

Values in beats per minute · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Pre-Infusion Heart Rate	67.8	13.3	Not reported	Not reported	Not reported
Post-Infusion Heart Rate	66.9	13.6	Not reported	Not reported	Not reported
Absolute Change in Heart Rate	0.9	11.2	Not reported	Not reported	Not reported

Complete source fields

classes

denoms

description

Patient vital signs were measured before and after 68Ga-PSMA-11 injections and absolute mean change was calculated.

dispersion Type

Standard Deviation

groups

param Type

MEAN

reporting Status

POSTED

time Frame

1 day

title

Safety Assessment - Heart Rate

type

SECONDARY

unit Of Measure

beats per minute

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice